IP Library Granted Patent US 7,275,933
Granted Patent B2
US 7,275,933 · App. 10/862,177 · Granted Oct 2, 2007

Method of manufacturing dental restorations

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,275,933
App. No.
10/862,177
Granted
Oct 2, 2007
Kind
B2
Abstract

Method of manufacturing dental restorations using curable compositions including degradable macromonomers having one or more terminal acrylate or methacrylate functionality, a curing composition, a filler composition including bioactive particles of bioactive glass, bioactive glass-ceramics, calcium phosphates, calcium apatites, or mixtures thereof and optionally one or more polymerizable acrylate or methacrylate comonomers. Degradable macromonomers are manufactured from cyclic monomers with compounds having acrylate or methacrylate functionality. Depending on their use, the degradable macromonomer compositions further include one or more organic or inorganic fillers, including a calcium-based compound and/or a radiopacity-imparting agent. The compositions are particularly suitable for root canal sealants, implants, bone cements, and pulp capping materials.

Claims (25)

1. A method of forming a dental or medical restoration comprising:

preparing a site to be restored in a tooth or bone; and

applying a composition comprising

(a) at least one degradable macromonomer having terminal acrylate or methacrylate groups and consisting essentially of the reaction product of lactide, glycolide, or a mixture thereof in the presence of a compound having at least one active hydrogen and at least one acrylate or methacrylate functionality;

(b) a curing composition;

(c) a filler composition comprising bioactive particles of bioactive glass, bioactive glass-ceramics, bioactive calcium phosphates, bioactive calcium apatites, or mixtures thereof; and

(d) optionally one or more co-polymerizable acrylate or methacrylate monomers; and curing the compositions.

2. The method of claim 1 , wherein the active hydrogen is a hydroxyl hydrogen.

3. The method of claim 1 , wherein the compound is selected from the group consisting of hydroxyalkyl acrylates and methacrylates wherein the alkyl group has from 1 to 12 carbons, and mixtures thereof.

4. The method of claim 3 , wherein the compound is selected from the group consisting of 2-hydroxyethyl methacrylate, 2-hydroxyethyl acrylate, diethylene glycol monomethacrylate, diethylene glycol monoacrylate, hydroxypropyl methacrylate, hydroxypropyl acrylate, tetraethyleneglycol monomethacrylate, tetraethyleneglycol monoacrylate, pentaethyleneglycol methacrylate, hydroxypolyethyl methacrylate, pentaethyleneglycol monoacrylate, dipropyleneglycol monomethacrylate, dipropyleneglycol monoacrylate, phenoxyhydroxyphenyl methacrylate, and mixtures thereof.

5. A method of forming a dental or medical restoration comprising:

preparing a site to be restored in a tooth or bone; and

applying a composition comprising

(a) 2-(polycaprolactone)ethyl methacrylate;

(b) a curing composition;

(c) a filler composition comprising bioactive particles of bioactive glass, bioactive glass-ceramics, bioactive calcium phosphates, bioactive calcium apatites, or mixtures thereof; and

(d) optionally one or more co-polymerizable acrylate or methacrylate monomers; and curing the compositions.

6. The method of claim 1 , wherein the co-polymerizable acrylate or methacrylate monomer is a diluent monomer present in an amount effective to provide delivery to the restoration site using an applicator.

7. The method of claim 6 , wherein the diluent monomer is selected from the group consisting of liquid dimethacrylate, trimethacrylate, glycerol dimethacrylate, ethylene glycol dimethacrylate, tri(ethylene glycol) dimethacrylate, tetra(methylene glycol) dimethacrylate, polyethylene glycol dimethacrylate, trimethylolpropane trimethacrylate, 1,6-hexanediol dimethacrylate, 2-hydroxyethyl acrylate, and 1,3-butanediol dimethacrylate.

8. The method of claim 1 , wherein the curing composition is selected from the group consisting of light-activated polymerization initiators, heat-cure initiators, a self-curing two-part system, and combinations thereof.

9. The method of claim 1 , wherein the curing composition is a self-curing two-part system mixed prior to use comprising an initiator in one part and an accelerator in a second part whereby the two parts contain equal or various amounts of the degradable macromonomer and co-polymerizable acrylate or methacrylate monomer.

10. The method of claim 1 , wherein the filler composition further comprises non-bioactive particles comprising inorganic calcium compounds, calcium phosphates, calcium hydroxide, calcium oxide, tricalcium phosphate, poly(lactide), poly(glycolide), poly(lactide-co-glycolide), poly(methacrylate), silica, fumed silica, silicate glass, glass fibers, quartz, barium silicate, strontium silicate, barium borosilicate, strontium borosilicate, borosilicate, lithium silicate, amorphous silica, ammoniated or deammoniated calcium phosphate and alumina, zirconia, tin oxide, and titania and combinations thereof.

11. The method of claim 1 , wherein the degradable macromonomer having terminal acrylate or methacrylate groups is poly(lactide-2-hydroxyethyl methacrylate) (PLAMA).

12. The method of claim 1 , wherein the degradable macromonomer having terminal acrylate or methacrylate groups is poly(glycolide-hydroxy ethyl methacrylate).

13. The method of claim 1 , wherein the degradable macromonomer having terminal acrylate or methacrylate groups is poly(lactide glycolide-hydroxy ethyl methacrylate) (PGLMA).

Assignments (8)
RELEASE OF SECURITY INTEREST Recorded Apr 9, 2021
From: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
To: KERR CORPORATION
Reel/Frame 055886/0185 →
SECURITY INTEREST Recorded May 8, 2020
From: KERR CORPORATION
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 052611/0362 →
RELEASE OF SECURITY INTEREST Recorded Aug 13, 2008
From: COHEN, GORDON S.; THE COHEN FAMILY TRUST PARTNERSHIP
To: PENTRON CLINICAL TECHNOLOGIES, LLC
Reel/Frame 021380/0321 →
AMENDMENT NO. 3 TO MORTGAGE AND SECURITY AGREEMENT DATED MARCH 9, 2005, AMENDED JULY 24, 2006 AND SECOND AMENDMENT DATED JUNE 15, 2007 Recorded Nov 1, 2007
From: PENTRON CLINICAL TECHNOLOGIES, LLC
To: COHEN, GORDON S.; THE COHEN FAMILY TRUST PARTNERSHIP
Reel/Frame 020054/0349 →
AMENDMENT NO. 2 TO MORTGAGE AND SECURITY AGREEMENT DATED MARCH 9, 2005 AND AMENDED JULY 24, 2006 Recorded Oct 25, 2007
From: PENTRON CLINICAL TECHNOLOGIES, LLC
To: COHEN, GORDON S.; THE COHEN FAMILY TRUST PARTNERSHIP
Reel/Frame 020010/0859 →
AMENDMENT TO MORTGAGE AND SECURITY AGREEMENT RECORDED AT REEL 015748 AND FRAME 0592 ON MARCH 9, 2005 Recorded Sep 29, 2006
From: PENTRON CLINICAL TECHNOLOGIES, LLC
To: COHEN, GORDON S.; THE COHEN FAMILY TRUST PARTNERSHIP
Reel/Frame 018323/0233 →
SECURITY AGREEMENT Recorded Mar 9, 2005
From: PENTRON CLINICAL TECHNOLOGIES, LLC
To: COHEN, GORDON S.; THE COHEN FAMILY TRUST PARTNERSHIP
Reel/Frame 015748/0592 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 5, 2004
From: JIA, WEITAO; JIN, SHUHUA
To: PENTRON CLINICAL TECHNOLOGIES, LLC
Reel/Frame 015662/0306 →